These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11201801)
61. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity. Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367 [TBL] [Abstract][Full Text] [Related]
62. [Death of a case caused by anaphylaxis to azithromycin]. Yang YZ Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):935. PubMed ID: 15733367 [No Abstract] [Full Text] [Related]
63. Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin. Cadle RM; Darouiche RO; Ashton CM Ann Pharmacother; 1997 Nov; 31(11):1308-10. PubMed ID: 9391684 [TBL] [Abstract][Full Text] [Related]
64. Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer. Koutras AK; Mastronikolis NS; Evans TR; Papadeas ES; Makatsoris T; Kalofonos HP Acta Oncol; 2008; 47(6):1171-3. PubMed ID: 18615326 [No Abstract] [Full Text] [Related]
65. [Clinical study of the ototoxicity of cisplatin]. Basterra J; Iranzo C; Marco J An Otorrinolaringol Ibero Am; 1985; 12(2):167-72. PubMed ID: 4039901 [No Abstract] [Full Text] [Related]
66. Experimental evidence of ototoxicity of ear drops. A review of the literature. Kuhweide R Acta Otorhinolaryngol Belg; 1995; 49(3):293-8. PubMed ID: 7484150 [TBL] [Abstract][Full Text] [Related]
68. [Severe liver damage caused by intravenous infusion of azithromycin in a case]. An N; Gui XM; Wang YH Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):313. PubMed ID: 16780660 [No Abstract] [Full Text] [Related]
69. [Delirium associated with azithromycin administration]. Sirois F Can J Psychiatry; 2002 Aug; 47(6):585-6. PubMed ID: 12211892 [No Abstract] [Full Text] [Related]
70. Azithromycin-induced intrahepatic cholestasis. Longo G; Valenti C; Gandini G; Ferrara L; Bertesi M; Emilia G Am J Med; 1997 Feb; 102(2):217-8. PubMed ID: 9217574 [No Abstract] [Full Text] [Related]
71. Myalgia and swelling of interphalangeal joints as side-effect of prolonged azithromycin therapy in patient with pelvic actinomycosis: case report. Desnica B; Beus A; Skuhala T; Topic MB; Vickovic N; Makek N Scand J Infect Dis; 2007; 39(2):186-7. PubMed ID: 17366044 [No Abstract] [Full Text] [Related]
72. Possible increased anticoagulation effect of warfarin induced by azithromycin. Woldtvedt BR; Cahoon CL; Bradley LA; Miller SJ Ann Pharmacother; 1998 Feb; 32(2):269-70. PubMed ID: 9496419 [No Abstract] [Full Text] [Related]
73. Fixed drug eruption probably induced by azithromycin. An I; Demir V; Akdeniz S Australas J Dermatol; 2017 Nov; 58(4):e253-e254. PubMed ID: 28726337 [No Abstract] [Full Text] [Related]
77. Cardiovascular risks with azithromycin. Svanström H; Pasternak B; Hviid A N Engl J Med; 2013 Aug; 369(6):580-1. PubMed ID: 23924016 [No Abstract] [Full Text] [Related]
78. Azithromycin and the risk of cardiovascular death. Pires dos Santos R; Kuchenbecker R N Engl J Med; 2012 Aug; 367(8):774-5; author reply 775. PubMed ID: 22913697 [No Abstract] [Full Text] [Related]
79. Azithromycin and the risk of cardiovascular death. Koga T; Imaoka H N Engl J Med; 2012 Aug; 367(8):774; author reply 775. PubMed ID: 22913696 [No Abstract] [Full Text] [Related]
80. Azithromycin and the risk of cardiovascular death. Louie R N Engl J Med; 2012 Aug; 367(8):774; author reply 775. PubMed ID: 22913695 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]